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INTRODUCTION
Cancer has been the most common cause of death in Korea
since 1983 (1) and poses a major public health concern. Over
140,000 new cancer cases are diagnosed annually in Korea
and one out of four deaths results from cancer (2, 3). This
paper gives an overview of the nationwide cancer statistics,
including the incidence, mortality, and survival rates, and
their trends in Korea. This report is a part of Special Article
series that presents the annually updated nationwide cancer
statistics in Korea. 
MATERIALS AND METHODS
Data sources
The Korea Ministry of Health and Welfare started a nation-
wide, hospital-based cancer registry called the Korea Central
Cancer Registry (KCCR) in 1980. Details of the history, ob-
jectives, and activities of the KCCR have been documented
(4). Incidence data from 1999 to 2005 were obtained from
the Korea National Cancer Incidence Database (KNCI DB).
Cancer cases were classified according to the International Clas-
sification of Diseases for Oncology 3rd edition (5) and converted
according to the International Classification of Diseases 10th edi-
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Cancer Statistics in Korea: Incidence, Mortality and Survival in 2005
Cancer has been the most common cause of death in Korea since 1983 and is a
major public health concern. This paper overviews the nationwide cancer statistics,
including incidence, mortality, and survival rates, and their trends in Korea. In 2005,
142,610 new cancer cases and 65,117 cancer deaths occurred in Korea. The inci-
dence rate for all cancer combined increased by 2.6% annually from 1999 to 2005.
Significant increases have occurred in the incidence of colorectal, thyroid, female
breast, and prostate cancers. The number of cancer deaths has increased over
the past two decades, due mostly to population aging, while the age-standardized
mortality rates have decreased in both men and women since 2002. Notable im-
provement has been observed in the 5-yr relative survival rates for most major can-
cers and for all cancer combined, with the exception of pancreatic cancer. The nation-
wide cancer statistics in this paper will provide essential data for  evidence-based
decisions in the national cancer control program in Korea. 
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� SPECIAL ARTICLE�tion (ICD-10) (6). The survival analysis used 1,151,789 can-
cer cases first diagnosed during 1993-2005 from the KNCI
DB, and followed vital status through 31 December 2006.
Mortality data from 1983 to 2005 were obtained from the
Korea National Statistics Office (KNSO) (1). Cause of death
was coded and classified according to the ICD-10. The pop-
ulation data were also obtained from KNSO using the resi-
dent registration population on 1 July.
Analysis
Crude rates (CRs) and age-specific rates of cancer incidence
and mortality were calculated. Age-standardized rates (ASRs)
were determined using the World Health Organization (WHO)
world standard population (7). The cumulative risks of can-
cer incidence, which are the probability of developing can-
cer to the life expectancy, were also calculated. Changes in
the annual age-standardized cancer incidence rates were exam-
ined by calculating the annual percentage change (APC) over
a time period as 100(e-1), where e is the slope of the regres-
sion of log age-standardized rates on a calendar year (8).
The survival duration of each case was determined as the
time difference between the date of initial diagnosis and the
date of death, date of loss to follow-up, or closing date for
follow-up. Observed survival rates were calculated using a
life table method and relative survival rates were examined
with the Ederer II method (9) using an algorithm written in
SAS by Paul Dickman (10), with some minor adaptations. 
SELECTED FINDINGS
Incidence
Table 1 presents the number of new cancer cases during
2005 in Korea by sex and cancer site. In 2005, 142,610 can-
cer incident cases were observed. The CRs of all sites com-
bined were 317.8 and 268.0 per 100,000 in men and women,
respectively, and the ASRs of all sites combined were 303.5
and 201.4 per 100,000 (Table 2). The cumulative risks for
developing a cancer to the life expectancy were 32.3% for
men and 26.5% for women.
Table 2 ranks cancer incidence and mortality by sex in 2005.
In males, the five leading primary sites of cancer were the
stomach (CR 69.7, ASR 65.5), lung (CR 50.5, ASR 50.2),
liver (CR 46.1, ASR 42.0), colon & rectum (CR 42.0, ASR
39.6), and prostate (CR 14.3, ASR 14.7), accounting for about
70% of all newly diagnosed cancers. In females, the most com-
996 K.-W. Jung, Y.-J. Won, S. Park, et al.
New cases
Sites
Both sexes Males Females
Deaths
Both sexes Males Females
All sites 142,610 77,566 65,044 65,117 41,131 23,986
Lip, oral cavity & pharynx 2,151 1,558 593 844 650 194
Esophagus 2,019 1,864 155 1,422 1,309 113
Stomach 25,809 17,024 8,785 10,935 7,146 3,789
Colon & rectum 17,625 10,253 7,372 5,997 3,259 2,738
Liver 14,907 11,264 3,643 10,877 8,188 2,689
Gallbladder* 4,166 2,094 2,072 3,328 1,694 1,634
Pancreas 3,703 2,050 1,653 3,373 1,862 1,511
Larynx 1,132 1,047 85 629 567 62
Lung 16,949 12,339 4,610 13,733 10,098 3,635
Breast 9,898 56 9,842 1,589 16 1,573
Cervix uteri 3,737 - 3,737 1,066 - 1,066
Corpus uteri 1,146 - 1,146 151 - 151
Ovary 1,544 - 1,544 751 - 751
Prostate 3,487 3,487 - 900 900 -
Testis 148 148 - 11 11 -
Kidney 2,299 1,569 730 658 449 209
Bladder 2,905 2,331 574 905 674 231
Brain & CNS 1,552 810 742 1,163 622 541
Thyroid 12,649 1,765 10,884 327 83 244
Hodgkin’s disease 154 104 50 35 25 10
Non-Hodgkin’s lymphoma 2,937 1,640 1,297 1,253 760 493
Multiple myeloma 772 400 372 521 270 251
Leukemia 2,289 1,292 997 1,438 794 644
Other & ill-defined 8,632 4,471 4,161 3,211 1,754 1,457
Table 1. Number of cancer cases and deaths by sex during 2005 in Korea
*Includes gallbladder and other/unspecified parts of biliary tract.
CNS, central nervous system.mon cancer sites were the thyroid (CR 44.8, ASR 35.0), breast
(CR 40.5, ASR 31.0), stomach (CR 36.2, ASR 26.3), colon
& rectum (CR 30.4, ASR 22.2), lung (CR 19.0, ASR 13.2),
and cervix uteri (CR 15.4, ASR 11.5), accounting for about
69% of all newly diagnosed cancers.
From the construction of a KNCI DB for 1999 onward
to 2005, the completeness of the Korea cancer registry data
has improved gradually. This might have contributed in part
to the gradual overall increases in cancer incidence, especial-
ly among the elderly. Nonetheless, the increases in thyroid,
colorectal and breast cancers in women and prostate cancer
in men are notable.
Mortality
In 2005, 65,117 cancer deaths were reported in Korea, ac-
counting for about 26.7% of all deaths (Table 3). The CRs of
all sites combined were 168.5 and 98.8 per 100,000 for men
and women, respectively, and the ASRs of all sites combined
were 166.6 and 68.8 per 100,000 (Table 4). Cancers of the
lung, stomach, liver and colon & rectum were the most common
fatal cancers, which accounted for 64% of all cancer deaths.
In men, the five leading primary cancer sites for mortality
were the lung (CR 41.4, ASR 41.7), liver (CR 33.5, ASR
31.1), stomach (CR 29.3, ASR 28.9), colon & rectum (CR
13.4, ASR 13.5), and pancreas (CR 7.6, ASR 7.6). In women,
the most common cancer sites for mortality were the stom-
ach (CR 15.6, ASR 10.5), lung (CR 15.0, ASR 10.0), colon
Cancer Statistics in Korea, 2005 997
Crude incidence rates per 100,000
Sites
Both sexes Males Females
Age-standardized incidence rates per 100,000*
Both sexes Males Females
All sites 292.9 317.8 268.0 240.8 303.5 201.4
Lip, oral cavity & pharynx 4.4 6.4 2.4 3.7 5.9 1.9
Esophagus 4.1 7.6 0.6 3.5 7.5 0.4
Stomach 53.0 69.7 36.2 43.4 65.5 26.3
Colon & rectum 36.2 42.0 30.4 29.8 39.6 22.2
Liver 30.6 46.1 15.0 25.4 42.0 11.1
Gallbladder
� 8.6 8.6 8.5 7.0 8.6 5.9
Pancreas 7.6 8.4 6.8 6.2 8.2 4.7
Larynx 2.3 4.3 0.4 2.0 4.2 0.3
Lung 34.8 50.5 19.0 28.5 50.2 13.2
Breast 20.3 0.2 40.5 15.8 0.2 31.0
Cervix uteri -- 15.4 -- 11.5
Corpus uteri -- 4.7 --3.7
Ovary -- 6.4 --5.1
Prostate - 14.3 -- 14.7 -
Testis - 0.6 -- 0.5 -
Kidney 4.7 6.4 3.0 4.0 5.9 2.4
Bladder 6.0 9.5 2.4 4.9 9.4 1.6
Brain & CNS 3.2 3.3 3.1 3.0 3.3 2.7
Thyroid 26.0 7.2 44.8 20.5 5.8 35.0
Hodgkin’s disease 0.3 0.4 0.2 0.3 0.4 0.2
Non-Hodgkin’s lymphoma 6.0 6.7 5.3 5.1 6.3 4.2
Multiple myeloma 1.6 1.6 1.5 1.3 1.6 1.1
Leukemia 4.7 5.3 4.1 4.6 5.4 4.0
Other & ill-defined 17.7 18.3 17.1 15.2 18.1 13.0
Table 2. Crude and age-standardized cancer incidence rates by sex during 2005 in Korea
*Age-standardized to the WHO world standard population; 
�
Includes gallbladder and other/unspecified parts of biliary tract.
CNS, central nervous system.
*Age-standardized to the WHO world standard population.
Source: Mortality Data, 2006, Korea National Statistical Office.
Rank Cause of death
Number 
of 
deaths
Percent 
of all
deaths
Age-stan-
dardized
death rate*
All causes 243,880 100.0 415.5
1 Cancer 65,117 26.7 109.1
2 Cerebrovascular disease 31,195 12.8 50.9
3 Heart disease 19,109 7.8 31.7
4 Intentional self harm (suicide) 12,011 4.9 20.2
5 Diabetes mellitus 11,776 4.8 19.4
6 Disease of liver 8,392 3.4 14.0
7 Transport accidents 7,935 3.3 14.2
8 Chronic lower respiratory  7,549 3.1 12.2
diseases
9 Hypertensive diseases 4,520 1.9 7.5
10 Pneumonia 4,131 1.7 7.0
All other & ill-defined causes 72,148 29.6 -
Table 3. Ten leading causes of death during 2005 in Korea& rectum (CR 11.3, ASR 7.5), liver (CR 11.1, ASR 7.9),
and gallbladder (CR 6.7, ASR 4.5).
Trends in cancer incidence
Tables 5.1-5.3 show the trends in cancer incidence for all
sites combined and for selected cancer sites. The incidence
rate for all sites combined increased by 2.5% annually from
1999 to 2005. The incidence rate for all sites combined in-
creased by 1.2% annually in men and by 4.1% in women
from 1999 to 2005.
The incidence rates have continued to increase for colorec-
tal and thyroid cancer in both sexes, along with breast can-
cer in females and prostate cancer in males. Stomach and lung
cancer incidence rates plateaued in men and women, while
the incidences of liver cancer in both sexes and the cervix in
women have decreased.
One notable aspect is the sharp increase (25.1% annually)
in the incidence of female thyroid cancer. As diagnostic tech-
niques for thyroid cancer have become more sensitive, such
as with the advent of ultrasound and fine-needle aspiration,
the detection of subclinical disease has become possible. There-
fore, the increased incidence of thyroid cancer might reflect
improved diagnostic techniques for previously undetected
disease, rather than a true increase in the occurrence of thy-
roid cancer (11, 12). 
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Crude mortality rates per 100,000
Sites
Both sexes Males Females
Age-standardized mortality rates per 100,000*
Both sexes Males Females
All sites 133.8 168.5 98.8 109.1 166.6 68.8
Lip, oral cavity & pharynx 1.7 2.7 0.8 1.4 2.5 0.6
Esophagus 2.9 5.4 0.5 2.4 5.3 0.3
Stomach 22.5 29.3 15.6 18.0 28.9 10.5
Colon & rectum 12.3 13.4 11.3 9.9 13.5 7.5
Liver 22.3 33.5 11.1 18.5 31.1 7.9
Gallbladder
� 6.8 6.9 6.7 5.5 7.0 4.5
Pancreas 6.9 7.6 6.2 5.7 7.6 4.2
Larynx 1.3 2.3 0.3 1.0 2.4 0.2
Lung 28.2 41.4 15.0 22.9 41.7 10.0
Breast 3.3 0.1 6.5 2.6 0.1 4.9
Cervix uteri -- 4.4 -- 3.1
Corpus uteri -- 0.6 -- 0.5
Ovary -- 3.1 -- 2.3
Prostate - 3.7 -- 4.3 -
Testis - 0.0 -- 0.0 -
Kidney 1.4 1.8 0.9 1.1 1.8 0.6
Bladder 1.9 2.8 1.0 1.5 3.0 0.6
Brain & CNS 2.4 2.5 2.2 2.1 2.4 1.8
Thyroid 0.7 0.3 1.0 0.5 0.3 0.7
Hodgkin’s disease 0.1 0.1 0.0 0.1 0.1 0.0
Non-Hodgkin’s lymphoma 2.6 3.1 2.0 2.1 3.0 1.5
Multiple myeloma 1.1 1.1 1.0 0.9 1.1 0.7
Leukemia 3.0 3.3 2.7 2.7 3.3 2.2
Other & ill-defined 6.6 7.2 6.0 5.5 7.3 4.3
Table 4. Crude and age-standardized cancer mortality rates by sex during 2005 in Korea
*Age-standardized to the WHO world standard population; 
� Includes gallbladder and other/unspecified parts of biliary tract.
CNS, central nervous system.
Fig. 1. Annual age-standardized cancer incidence and death rates
for all sites by sex during 1983-2005 in Korea.
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Years
Sites APC*
1999 2000 2001 2002 2003 2004 2005
All sites 210.5  205.1  216.7  220.1  225.2  230.8  240.8  2.5
�
Lip, oral cavity & pharynx 3.6  4.4  3.6  3.7  3.7  3.7  3.7  -0.9
Esophagus 4.1 3.7  3.9 3.8 3.6 3.5  3.5  -2.1
�
Stomach 43.6 42.3  44.0 43.6 43.1 40.5  43.4 -0.4
Colon & rectum 20.4  21.0  22.9  24.7  26.4  27.9  29.8  6.8
�
Liver 27.9 26.7  27.3 26.5 25.7 25.4  25.4 -1.6
�
Gallbladder
� 6.5 6.4  6.7 6.7 6.6 6.9  7.0  1.3
�
Pancreas 5.6 5.5  5.5 5.8 5.8 6.0  6.2  1.9
�
Larynx 2.3 2.2  2.4 2.2 2.1 1.9  2.0  -3.3
�
Lung 28.5 27.7  28.3 28.5 27.8 28.6  28.5  0.2
Breast 10.7 10.8  12.7 13.9 14.0 14.5  15.8  6.8
�
Kidney 3.0 2.9  3.3 3.4 3.5 3.7  4.0  5.1
�
Bladder 4.6 4.6  4.9 4.7 5.0 5.0  4.9  1.3
Brain & CNS 2.9  2.8  2.8  2.6  2.9  2.9  3.0  0.8
Thyroid 6.3 6.1  7.9 9.5  12.5  17.2  20.5  24.2
�
Hodgkin’s disease 0.2  0.3  0.3  0.3  0.3  0.4  0.3  4.4
Non-Hodgkin’s lymphoma 4.5  4.2  4.5  4.6  4.9  5.1  5.1  3.2
�
Multiple myeloma 1.0  1.0  1.1  1.1  1.1  1.2  1.3  4.2
�
Leukemia 4.7 4.3  4.7 4.8 4.7 4.7  4.6  0.7
Other & ill-defined 14.3  13.5  13.9  13.5  14.6  14.5  15.2  1.4
Table 5-1. Trends in cancer incidence rates in both sexes during 1999-2005 in Korea
*annual percent change using age-standardized incidence based on the WHO world standard population; 
�
Includes gallbladder and other/unspeci-
fied parts of biliary tract; 
�
The APC is significantly different from zero (P<0.05).
CNS, central nervous system.
Years
Sites APC*
1999 2000 2001 2002 2003 2004 2005
All sites 285.0  276.7  288.3  290.0  292.3  294.8  303.5  1.2*
Lip, oral cavity & pharynx 6.1  7.1  6.0  6.2  6.4  6.0  5.9  -1.3
Esophagus 8.8 8.0  8.3 8.2 7.7 7.6 7.5  -2.2
�
Stomach 66.2 65.0  67.2 66.6 65.7 61.5 65.5 -0.6
Colon & rectum 26.2  27.2  29.6  32.9  34.7  36.9  39.6  7.5
�
Liver 46.8 44.7  45.1 43.9 42.3 42.0 42.0 -1.8
�
Gallbladder
� 8.1 7.8  8.2 8.1 7.8 8.4 8.6  1.0
Pancreas 7.8 7.6  7.6 7.9 7.7 8.0 8.2  0.9
Larynx 4.9 4.5  5.1 4.7 4.4 4.0 4.2  -3.0
�
Lung 51.4 49.8  51.1 51.0 49.9 50.6 50.2 -0.2
Breast 0.2 0.3  0.2 0.3 0.2 0.2 0.2  -0.7
Prostate 8.4 7.2  9.5  10.1  12.0  14.4  14.7  12.6
�
Testis 0.6 0.5  0.6 0.6 0.6 0.6 0.5  1.1
Kidney 4.5 4.4  4.9 5.0 5.1 5.5 5.9  4.6
�
Bladder 9.0 9.0  9.4 9.0 9.6 9.5 9.4  1.0
Brain & CNS 3.2  3.1  3.1  2.9  3.3  3.3  3.3  0.8
Thyroid 2.1 1.9  2.4 2.7 3.6 4.8 5.8  20.7
�
Hodgkin’s disease 0.4  0.4  0.4  0.3  0.4  0.5  0.4  3.4
Non-Hodgkin’s lymphoma 5.8  5.5  5.8  5.8  6.1  6.5  6.3  2.2
�
Multiple myeloma 1.2  1.3  1.4  1.4  1.4  1.4  1.6  3.8
�
Leukemia 5.5 5.0  5.4 5.8 5.4 5.6 5.4  0.7
Other & ill-defined 17.9  16.5  16.8  16.5  17.9  17.4  18.1  0.8
Table 5-2. Trends in cancer incidence rates in males during 1999-2005 in Korea
*annual percent change using age-standardized incidence based on the WHO world standard population; 
�
Includes gallbladder and other/unspeci-
fied parts of biliary tract; 
�
The APC is significantly different from zero (P<0.05).
CNS, central nervous system.Trends in cancer mortality
Figs. 1&2 show the trends in cancer deaths for all sites com-
bined and for selected cancer sites. Age-standardized mor-
tality rates have decreased for all sites combined in both sexes
since 2002.
For lung cancer, the leading site for cancer deaths since
1999, mortality has decreased slightly for men since 2001,
but increased significantly in women. The age-standardized
mortality rates of stomach and cervix uteri cancer have dec-
reased continuously. Along with the significant increases in
colorectal, prostate and female breast cancer incidence, the
mortality rates of these cancers have also continued to in-
crease.
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Years
Sites APC*
1999 2000 2001 2002 2003 2004 2005
All sites 161.1  157.4  169.0  174.6  181.8  190.0  201.4  4.1
�
Lip, oral cavity & pharynx 1.6  2.4  1.7  1.7  1.6  1.8  1.9  -0.6
Esophagus 0.6 0.6  0.6 0.5 0.6 0.5 0.4  -3.9
Stomach 26.7 25.2  26.2 26.3 25.8 24.3 26.3 -0.5
Colon & rectum 16.4  16.4  17.9  18.8  20.2  21.0  22.2  5.5
�
Liver 12.3 11.8  12.2 11.8 11.5 11.2 11.1 -1.7
�
Gallbladder
� 5.3 5.5  5.7 5.8 5.8 5.8 5.9  1.6
�
Pancreas 4.0 4.0  4.0 4.2 4.4 4.5 4.7  3.0
�
Larynx 0.4 0.3  0.3 0.3 0.3 0.3 0.3  -8.0
�
Lung 12.4 12.5  12.3 12.6 12.3 13.0 13.2  0.9
Breast 20.9 20.9  24.7 27.2 27.4 28.5 31.0  7.2
�
Cervix uteri 16.3  15.1  15.8  14.8  14.0  12.9  11.5  -5.9
�
Corpus uteri 2.8  2.6  3.0  3.3  3.7  3.7  3.7  6.6
�
Ovary 5.0 4.8  4.8 5.0 5.1 5.1 5.1  0.7
Kidney 1.7 1.8  1.9 2.0 2.1 2.2 2.4  5.4
�
Bladder 1.6 1.6  1.7 1.7 1.8 1.7 1.6  0.7
Brain & CNS 2.6  2.5  2.5  2.4  2.5  2.6  2.7  0.8
Thyroid 10.4 10.1  13.2 16.2 21.5 29.5 35.0  25.1
�
Hodgkin’s disease  0.1  0.2  0.2  0.2  0.2  0.2  0.2  5.5
Non-Hodgkin’s lymphoma 3.4  3.2  3.4  3.5  3.9  4.0  4.2  4.5
�
Multiple myeloma 0.8  0.8  0.9  0.8  0.9  1.0  1.1  5.2
�
Leukemia 3.9 3.8  4.1 4.0 4.1 4.0 4.0  0.6
Other & ill-defined 11.8  11.5  11.8  11.5  12.2  12.4  13.0  1.8
�
Table 5-3. Trends in cancer incidence rates in females during 1999-2005 in Korea
*annual percent change using age-standardized incidence based on the WHO world standard population; 
�
Includes gallbladder and other/unspeci-
fied parts of biliary tract; 
�
The APC is significantly different from zero (P<0.05).
CNS, central nervous system.
Fig. 2. Annual age-standardized cancer mortality for selected cancers by sex during 1983-2005 in Korea.
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Males FemalesAge-specific incidence rates for selected cancer sites
Table 6 presents the most common cancer sites by sex and
age group. For ages 0-14 yr, leukemia was the most common
form in both sexes. For males, stomach cancer was the most
common in 15-64-yr-olds, while lung cancer was more fre-
quent for those 65 and over. For females, the most common
sites of cancer were the thyroid, breast and stomach for the
15-34-yr-old, 35-64-yr-old, and the 65 and over age groups,
respectively. Fig. 3 shows the age-specific incidence rates of
the selected cancers for men and women. The data show that
the incidence of stomach, lung, liver and colorectal cancers
increased gradually with age. In women, the age-specific inci-
dence rates of breast and thyroid cancer has increased with
age until the forties and decreased thereafter.
Survival rates
Table 7 shows the 5-yr relative survivals for three periods:
1993-1995, 1996-2000, and 2001-2005. Notable improve-
ment has been made in the 5-yr relative survival rates for
all sites combined. The survival of females appears to have a
better prognosis than that of males. This is partly explain-
ed by the high frequency of female cancers (e.g., thyroid, bre-
ast and uterine cervix) known to have relatively good prog-
noses.
The 5-yr relative survival rates appeared to be higher for
most major cancer sites in patients diagnosed during 2001-
2005 compared to 1993-1995, except for cancers of the pan-
creas, brain and central nervous system. The greatest improve-
ments were seen in leukemia, non-Hodgkin’s lymphoma,
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Rank
Age-specific incidence rate per 100,000
65 yr 
and over 
35-64 yr 15-34 yr 0-14 yr
Rank
Age-specific incidence rate per 100,000
65 yr 
and over 
35-64 yr 15-34 yr 0-14 yr
Males
1 Leukemia Stomach Stomach Lung
(4.1) (3.9) (92.3) (478.6)
2 Brain & CNS Thyroid Liver Stomach
(2.1) (3.5) (74.8) (454.5)
3 Non-Hodgkin’s Leukemia Colon  &  Colon  &
lymphoma (3.1) rectum rectum
(1.4) (55.5) (274.5)
4 Liver Non- Lung Liver
(0.5) Hodgkin’s (43.8) (220.0)
lymphoma
(2.3)
5 Kidney Colon & Thyroid Prostate
(0.4) rectum (12.8) (157.0)
(2.3)
Females
1 Leukemia Thyroid Breast Stomach
(3.6) (23.9) (82.1) (165.8)
2 Brain & CNS Breast Thyroid Colon &
(1.8) (9.6) (81.6) rectum
(150.3)
3 Non-Hodgkin’s Stomach Stomach Lung
lymphoma (4.8) (42.3) (116.3)
(0.8)
4 Ovary Cervix uteri Colon & Liver
(0.6) (4.1) rectum (74.2)
(34.3)
5 Kidney Ovary Cervix uteri Gallbladder*
(0.4) (2.8) (25.7) (54.6)
Table 6. Five major sites of cancer incidence by age group and sex during 2005 in Korea
*Includes gallbladder and other/unspecified parts of biliary tract.
CNS, central nervous system.
Fig. 3. Age-specific incidence rates of major cancers during 2005 in Korea.
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The improving survival rates could be attributable to ear-
ly detection, as well as to improved treatments (13, 14), but
this needs to be evaluated further. Lack of progress in early
detection and treatment could explain the observed absen-
ce of improvement in the survival rate of pancreatic cancer
(15).
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